1,389
Views
8
CrossRef citations to date
0
Altmetric
Articles

The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapy

, , , , , , & show all
Pages 1581-1584 | Received 17 Nov 2020, Accepted 24 Nov 2020, Published online: 22 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Luca Potestio, Fabrizio Martora, Gabriella Fabbrocini, Teresa Battista & Matteo Megna. (2023) Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis. Psoriasis: Targets and Therapy 13, pages 11-18.
Read now
Paolo Gisondi, Davide Geat, Francesco Bellinato & Giampiero Girolomoni. (2022) Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis. Expert Opinion on Biological Therapy 22:12, pages 1521-1529.
Read now

Articles from other publishers (6)

Yu Meng, Furong Zeng, Huiyan Sun, Yayun Li, Xiang Chen & Guangtong Deng. (2022) Clinical characteristics and outcomes of patients with COVID‐19 and psoriasis. Journal of Medical Virology 94:12, pages 5850-5857.
Crossref
Mayumi Komine, Tuba Mussarat Ansary, Md Razib Hossain, Koji Kamiya & Mamitaro Ohtsuki. (2022) Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation?. International Journal of Molecular Sciences 23:20, pages 12260.
Crossref
Anna Campanati, Federico Diotallevi, Emanuela Martina, Giulia Radi & Annamaria Offidani. (2022) Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities. Journal of Clinical Medicine 11:9, pages 2422.
Crossref
Y. Lytvyn, J.R. Georgakopoulos, A. Mufti, A.R. Devani, M.J. Gooderham, V. Jain, P. Lansang, R. Vender, V.H. Prajapati & J. Yeung. (2021) Incidence and prognosis of COVID‐19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study. Journal of the European Academy of Dermatology and Venereology 36:2.
Crossref
Huanhuan Zeng, Siyu Wang, Ling Chen & Zhu Shen. (2021) Biologics for Psoriasis During the COVID-19 Pandemic. Frontiers in Medicine 8.
Crossref
Koji Kamiya, Mayumi Komine & Mamitaro Ohtsuki. (2021) Biologics for Psoriasis during the COVID-19 Pandemic. Journal of Clinical Medicine 10:7, pages 1390.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.